ARWR

ARROWHEAD PHARMACEUTICALS INC

Healthcare | Mid Cap

-$1.08

EPS Forecast

$107.3

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.08

Revenue Forecast:

$107.3

EPS Surprise Forecast:

-$0.039

Revenue Surprise Forecast:

$8

Post-release price volatility - High

Post-release Overnight Move:

±8.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

48%

Probability of beating revenue consensus:

66%

Probability of beating both EPS & revs consensus:

38%

Probability of missing both EPS & revs consensus:

24%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.65

Earnings volatility

EPS standard deviation:

$0.71

Revenue standard deviation:

$45

As % of share price:

1.25% EXTREME UNCERTAINTY

As % of market cap:

0.57% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.12

Revenue 95th %ile:

$169

EPS 75th %ile:

-$0.83

Revenue 75th %ile:

$124

EPS 25th %ile:

-$1.28

Revenue 25th %ile:

$93

EPS 5th %ile:

-$1.83

Revenue 5th %ile:

$56

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

93% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$12

Bid-ask per Share:

$0.065